GW-501516, also known as Cardarine, is a potent and selective agonist of the peroxisome proliferator-activated receptor delta (PPARδ). Research suggests that activation of PPARδ may enhance fatty acid oxidation, improve glucose metabolism, and increase mitochondrial activity, making GW-501516 a valuable compound for studies on energy balance and metabolic disorders. Preclinical investigations indicate it may also support enhanced endurance capacity by shifting energy utilization toward fat rather than glycogen, which has led to interest in its potential applications in obesity, dyslipidemia, and performance research.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.
